Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AC
2126
DELISTED
Associated Capital Group
AC
| $2.46M | ﹤0.01% |
68,541
-19,699
| -22% | -$714K |
|
2127
Hingham Institution for Saving
HIFS
$686M
| $2.44M | ﹤0.01% |
13,800
+2,700
| +24% | +$506K |
|
|
YIN
2128
DELISTED
Yintech Investment Holdings Limited American Depositary Shares
YIN
| $2.44M | ﹤0.01% |
+116,100
| New | +$2.1M |
|
2129
MacroGenics
MGNX
$259M
| $2.44M | ﹤0.01% |
+130,923
| New | +$2.53M |
|
2130
NeoGenomics
NEO
$2.11B
| $2.44M | ﹤0.01% |
+308,664
| New | +$2.51M |
|
2131
Flexsteel Industries
FLXS
$303M
| $2.43M | ﹤0.01% |
48,300
+31,800
| +193% | +$1.65M |
|
2132
Comp X International
CIX
$390M
| $2.43M | ﹤0.01% |
158,500
-5,900
| -4% | -$84.2K |
|
|
FNFV
2133
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $2.43M | ﹤0.01% |
183,600
-61,000
| -25% | -$767K |
|
2134
Chicago Rivet & Machine Co
CVR
$9.98M
| $2.43M | ﹤0.01% |
60,100
+2,000
| +3% | +$84.9K |
|
|
ICAD
2135
DELISTED
iCAD Inc
ICAD
| $2.41M | ﹤0.01% |
501,560
-16,000
| -3% | -$62K |
|
2136
St. Joe Company
JOE
$3.89B
| $2.41M | ﹤0.01% |
141,500
-2,100
| -1% | -$35.9K |
|
|
WMAR
2137
DELISTED
West Marine Inc
WMAR
| $2.41M | ﹤0.01% |
252,800
-36,501
| -13% | -$345K |
|
|
SEAC
2138
DELISTED
Seachange International Inc
SEAC
| $2.4M | ﹤0.01% |
48,445
+2,889
| +6% | +$142K |
|
2139
Westamerica Bancorp
WABC
$1.39B
| $2.4M | ﹤0.01% |
42,931
-90,769
| -68% | -$5.22M |
|
|
GTS
2140
DELISTED
Triple-S Management Corporation
GTS
| $2.4M | ﹤0.01% |
+143,371
| New | +$2.57M |
|
2141
Coherus Oncology
CHRS
$176M
| $2.39M | ﹤0.01% |
+113,200
| New | +$2.78M |
|
2142
Southern Missouri Bancorp
SMBC
$850M
| $2.39M | ﹤0.01% |
67,300
+18,600
| +38% | +$640K |
|
|
PMT
2143
PennyMac Mortgage Investment
PMT
$828M
| $2.39M | ﹤0.01% |
+134,530
| New | +$2.28M |
|
2144
Astronics
ATRO
$4.57B
| $2.39M | ﹤0.01% |
+103,776
| New | +$2.45M |
|
|
CFNL
2145
DELISTED
Cardinal Financial Corp
CFNL
| $2.39M | ﹤0.01% |
79,700
-53,600
| -40% | -$1.65M |
|
2146
Douglas Dynamics
PLOW
$967M
| $2.38M | ﹤0.01% |
77,700
+68,900
| +783% | +$2.24M |
|
2147
TransAlta
TAC
$3.99B
| $2.38M | ﹤0.01% |
406,600
-192,141
| -32% | -$1.09M |
|
2148
IRIDEX
IRIX
$14.3M
| $2.38M | ﹤0.01% |
200,304
+4,404
| +2% | +$61.9K |
|
2149
United Fire Group
UFCS
$1.38B
| $2.38M | ﹤0.01% |
55,600
+12,700
| +30% | +$571K |
|
|
KNGT
2150
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $2.38M | ﹤0.01% |
75,850
-53,400
| -41% | -$1.67M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.